WG
RGNX icon

Winton Group’s Regenxbio RGNX Stock Holding History

Winton Group’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$290K Buy
+24,200
New +$201K 0.01% 903
2024
Q4 		– Sell
-96,936
Closed -$1.02M – 756
2024
Q3 		$1.02M Buy
96,936
+20,096
+26% +$245K 0.07% 316
2024
Q2 		$899K Buy
76,840
+34,136
+80% +$531K 0.06% 326
2024
Q1 		$900K Buy
+42,704
New +$760K 0.06% 328
2023
Q2 		– Sell
-10,503
Closed -$199K – 1061
2023
Q1 		$199K Sell
10,503
-29,813
-74% -$660K 0.01% 908
2022
Q4 		$914K Buy
40,316
+3,312
+9% +$74.9K 0.06% 433
2022
Q3 		$978K Sell
37,004
-8,162
-18% -$242K 0.06% 422
2022
Q2 		$1.12M Buy
45,166
+30,967
+218% +$774K 0.06% 450
2022
Q1 		$471K Buy
+14,199
New +$394K 0.02% 699
2021
Q4 		– Sell
-11,986
Closed -$502K – 1323
2021
Q3 		$502K Buy
+11,986
New +$431K 0.03% 862
2020
Q3 		– Sell
-21,240
Closed -$782K – 1589
2020
Q2 		$782K Sell
21,240
-76,240
-78% -$2.84M 0.02% 1066
2020
Q1 		$3.16M Sell
97,480
-51,330
-34% -$2.14M 0.08% 421
2019
Q4 		$6.1M Buy
+148,810
New +$5.88M 0.09% 403
2019
Q2 		– Sell
-3,841
Closed -$220K – 1259
2019
Q1 		$220K Buy
+3,841
New +$190K ﹤0.01% 929
2018
Q4 		– Sell
-2,741
Closed -$207K – 1007
2018
Q3 		$207K Buy
+2,741
New +$197K ﹤0.01% 966

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Winton Group's RGNX Position: Q2 2026 in Review

Winton Group opened a new position in Regenxbio (RGNX) in Q2 2026: 24,200 shares worth $290K. The stake represents 0.01% of the portfolio and ranks #903 among its holdings. This is a return to the name: Winton Group previously reported a position in RGNX as recently as Q3 2024.

Winton Group first reported a position in RGNX in Q3 2018 and has held it in 15 quarters since. The position peaked at $6.1M in Q4 2019. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Winton Group held 24,200 shares of Regenxbio worth $290K as of Q2 2026.
  • Regenxbio was a new Winton Group position in Q2 2026.
  • Regenxbio made up 0.01% of Winton Group's portfolio in Q2 2026, its #903 holding.
  • Winton Group first reported a position in Regenxbio in Q3 2018 and has held it in 15 quarters since.
  • Winton Group's Regenxbio position peaked at $6.1M in Q4 2019.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.